Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 611-615

  Pepper, Chris ^a   Thomas, Alen ^a   Terry, Hoy ^b   Cotter, Finbarr ^c   Bentley, Paul ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Antisense; Apoptosis; B cell chronic lymphocytic leukaemia; Bax; Bcl 2

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CANCER RESISTANCE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032755034     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01726.x     Document Type: Article

References (20)

1. Aguílar-Santelises, M., Rottenberg, M.E., Lewin, N., Mellstedt, H. & Jondal, M. (1996) Bcl-2, bax and p53 expression in B-CLL, in relation to in vitro survival and clinical progression. International Journal of Cancer, 69, 114-119.
2. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C. & Boivin, P. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 48, 198-206.
3. Cotter, F.E., Johnson, P., Hall, P., Pocock, C., Al Mahdi, N. & Cowell, J.K. (1994) Antisense oligonucleotides suppress B-cell lymphoma growth in SCID-hu mouse model. Oncogene, 9, 3049-3055.
4. Ferlini, C., Di Cesare, S., Rainaldi, G., Malorni, W., Samoggia, P., Biselli, R. & Fattorossi, A. (1996) Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry, 24, 106-115.
5. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. & Reed, J.C. (1993) bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820-1828.
6. Keating, M.J., OBrien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., Freireich, E.J., Estey, E. & Kantarjian, H. (1998) Long term follow-up of patients with CLL receiving fludarabine regimens as initial therapy. Blood, 92, 1165-1171.
7. Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., Wang, H-G., Zhang, X., Bullrich, F., Croce, C.M., Rai, K., Hines, J. & Reed, J.C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood, 91, 3379-3389.
8. Kitada, S., Miyashita, T., Tanaka, S. & Reed, J.C. (1993) Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Research and Development, 3, 157-169.
9. McConkey, D.J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T.J., Reed, J.C. & Keating, M. (1996) Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. Journal of Immunology, 156, 2624-2630.
10. Oltvai, Z.N., Milliman, C.L. & Korsmeyer, S.J. (1993) bcl-2 heterodimerizes in vitro with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74, 609-619.
11. Pepper, C., Bentley, P. & Hoy, T. (1996) Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 95, 513-517.
12. Pepper, C., Hoy, T. & Bentley, P. (1997) Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. British Journal of Cancer, 76, 935-938.
13. Reed, J.C. (1995) bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematology/Oncology Clinics of North America, 9, 451-473.
14. Reed, J.C., Stein, C., Subasinghe, C., Haldar, S., Croce, C.M., Yum, S. & Cohen, J. (1990) Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Research, 50, 6565-6570.
15. Robertson, L.E., Plunkett, W., McConnell, K., Keating, M.J. & McDonnell, T.J. (1996) Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia, 10, 456-459.
16. Schena, M., Larsson, L-G., Gottardi, D., Gaidano, G., Carlsson, M., Nilsson, K. & Caligaris-Cappio, F. (1992) Growth and differentiation-associated expression of bcl-2 in chronic lymphocytic leukemia cells. Blood, 80, 2981-2989.
17. Thomas, A., El Rouby, S., Reed, J.C., Krajewski, S., Silber, R., Potmesil, M. & Newcomb, E.W. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12, 1055-1062.
18. Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. (1995) A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods, 184, 39-51.
19. Webb, A., Cunningham, D., Cotter, F., Clarke, P.A., di Stafano, F., Ross, P., Corbo, M. & Dziewanowska, Z. (1997) Bcl-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet, 349, 1137-1141.
20. Ziegler, A., Luedke, G.H., Fabbro, D., Altmann, K.H., Stahel, R.A. & Zangemeister-Wittke, U. (1997) Induction of apoptosis in small-cell lung cancer cells by an antisense oligonucleotide targeting the Bcl-2 coding sequence. Journal of the National Cancer Institute, 89, 1027-1035.